Monteiro-Reis, S.; Blanca, A.; Tedim-Moreira, J.; Carneiro, I.; Montezuma, D.; Monteiro, P.; Oliveira, J.; Antunes, L.; Henrique, R.; Lopez-Beltran, A.;
et al. A Multiplex Test Assessing MiR663ame and VIMme in Urine Accurately Discriminates Bladder Cancer from Inflammatory Conditions. J. Clin. Med. 2020, 9, 605.
https://doi.org/10.3390/jcm9020605
AMA Style
Monteiro-Reis S, Blanca A, Tedim-Moreira J, Carneiro I, Montezuma D, Monteiro P, Oliveira J, Antunes L, Henrique R, Lopez-Beltran A,
et al. A Multiplex Test Assessing MiR663ame and VIMme in Urine Accurately Discriminates Bladder Cancer from Inflammatory Conditions. Journal of Clinical Medicine. 2020; 9(2):605.
https://doi.org/10.3390/jcm9020605
Chicago/Turabian Style
Monteiro-Reis, Sara, Ana Blanca, Joana Tedim-Moreira, Isa Carneiro, Diana Montezuma, Paula Monteiro, Jorge Oliveira, LuÃs Antunes, Rui Henrique, António Lopez-Beltran,
and et al. 2020. "A Multiplex Test Assessing MiR663ame and VIMme in Urine Accurately Discriminates Bladder Cancer from Inflammatory Conditions" Journal of Clinical Medicine 9, no. 2: 605.
https://doi.org/10.3390/jcm9020605
APA Style
Monteiro-Reis, S., Blanca, A., Tedim-Moreira, J., Carneiro, I., Montezuma, D., Monteiro, P., Oliveira, J., Antunes, L., Henrique, R., Lopez-Beltran, A., & Jerónimo, C.
(2020). A Multiplex Test Assessing MiR663ame and VIMme in Urine Accurately Discriminates Bladder Cancer from Inflammatory Conditions. Journal of Clinical Medicine, 9(2), 605.
https://doi.org/10.3390/jcm9020605